Industry Bulletins | July 16, 2021
Wesana Health Announces Definitive Agreement To Acquire PsyTech Inc.
Wesana Health Holdings Inc. (Wesana), an emerging life sciences company focused on developing innovative approaches for better understanding, protecting, and improving neurological health and performance, including through the advancement of psilocybin-based medicine, announced the execution of a definitive agreement to acquire Psychedelitech Inc., also known as PsyTech Inc., for a price of approximately $21 million CAD in Wesana Healthstock (the transaction), as further described below.
The acquisition of PsyTech as a wholly owned subsidiary of Wesana will add three major components that will expand and enhance Wesana’s current business, including clinical software-as-a-service (SaaS) platform ‘Tovana . . .